Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

CaixaBank Launches AI Agent to Enhance In-App Purchases

New technology aims to simplify shopping experiences for users.Highlights: CaixaBank's new AI agent assists customers in making in-app...

Northern Trust Strengthens Asset Management with Tokenized Money Market Share Class

New offering aims to enhance liquidity and investment flexibility.Highlights: Northern Trust introduces a tokenized money market share class.This...

FundBank Strengthens Position with Acquisition of TRRUE Blockchain Firm

The acquisition enhances FundBank's capabilities in blockchain technology.Highlights: FundBank has acquired the Irish blockchain firm, TRRUE.The acquisition aims...

Visa Strengthens Ties as Anchor Investor in PayPay IPO

Visa commits to supporting PayPay's growth through IPO investment.Highlights: Visa invests as anchor in PayPay's IPO.This move highlights...